Blog Category: Neurology

Gene Therapy Shows Promise in Treating Parkinson’s in Humans

A study aimed at the treatment of patients with medically refractory Parkinson’s disease (PD), showed promising phase 2 results for a therapeutic approach to determine the safety and efficacy of AAV-GAD gene transfer into the subthalamic nucleus (STN) region of …

Brain Awareness Week 2011

Brain Awareness Week (BAW) is March 14-20, 2011.

BAW is the global campaign to increase public awareness about the progress and benefits of brain research. Every March BAW unites the efforts of organizations worldwide in a week-long celebration of the …

Warm Weather May Affect Cognition in Patients with MS

Research to be presented at the American Academy of Neurology’s 63rd Annual Meeting in Honolulu April 9 to April 16, 2011, found that warmer weather may make it harder for patients with multiple sclerosis (MS) to learn, remember or process …

MRI to Spot the Early Stages of Alzheimer’s Disease

Researchers at the National Institute for Health Research Biomedical Research Centre for Mental Health at the Maudsley Hospital, London, Kings College London, and the Karolinska Hospital, Stockholm, Sweden, are field testing an ‘Automated MRI’ software package that compares a …

Silk Moth Antenna Inspiration for New Nanotechnology Tool – Implications for Neurodegenerative Disease

New nanotechnology recently published online in Nature Nanotechnology, may have implications for Alzheimer’s and other neurodegenerative diseases.

A special coating on the nanotunnels of a silk moth’s antenna is the inspiration for a similar oily layer on synthetic nanopores. Nanopores …

Unrecognized bipolar disorder in primary care patients with depression

According to a study published in the British Journal of Psychiatry, As many as 1 in 5 people being treated for depression in primary care could have undiagnosed bipolar disorder.

Individuals who were being treated for depression (n=3,117) by …

L-methylfolate Plus Antidepressant Improves MDD

A new study published in Innovations in Clinical Neuroscience suggests that when L-methylfolate, a medical food available commercially and by prescription, is used for dietary management of depression in combination with an antidepressant drug at the start of depression therapy, …